Ligand Pharmaceuticals Inc LGND
News
Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
Ligand Reports Second Quarter 2024 Financial Results
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
Ligand to Acquire APEIRON Biologics AG for $100 Million
Ligand Pharmaceuticals Gets FDA OK for Viral Skin Infection Treatment